Details

Zugriffe: 5288

2014 (8 Publikationen)

• Szurman P, Gekeler KP. Sekundäre IOL-Implantation. Sklera-Nahtfixierte Intraokularlinsen. Ophthalmologe 2014; 111: 217-223 [IF 0.635]
• Mester U, Vaterrodt T, Goes F, Huetz W, Neuhann I, Schmickler S, Szurman P, Gekeler K. Impact of personality characteristics on patient satisfaction after implantation of multifocal intraocular lenses – results from the “Happy Patient Study”. Graefes Arch Clin Exp Ophthalmol 2014; 111: 1178-1182 [IF 2.102]
• Bertelmann T, Bertelmann I, Szurman P, Mester U, Schmidt J, Sekundo W, Mennel S. [Vitreous body and retinal vein occlusion]. Ophthalmologe. 2014; 111: 1178-1182 [IF 0.635]
• Januschowski K, Mueller S, Dollinger R, Schnichels S, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P. Thaler S. Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 935-941 [IF 2.102]
• Schultheiss M, Schnichels S, Mlynczak T, Dipl-Ing JH, Bartz-Schmidt KU, Szurman P, Spitzer MS. Cyclosporine a protects RGC-5 cells from excitotoxic cell death. J Glaucoma. 2014; 23: 219-224 [IF 2.102]
• Szurman P, Gekeler K. [Secondary intraocular lens implantation using scleral suture fixation]. Ophthalmologe 2014; 111: 217-223 [IF 0.635]
• Ziemssen F, Eter N, Fauser S, Bopp S, Radermacher M, Hasanbasic Z, Holz FG; AURA-Studiengruppe. Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany. Ophthalmologe. 2015; 112: 246-254 [IF 0.635]
• Januschowski K, Schnichels S, Hagemann U, Koch V, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Lüke M, Aisenbrey S. Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model. Acta Ophthalmol. 2014: 92: 305-311 [IF 3.032]

Details

Zugriffe: 5394

2015 (9 Publikationen)

• Mariacher S, Szurman P. [Artificial vitreous body: Strategies for vitreous body substitutes]. Ophthalmologe. 2015; 112: 572-579 [IF 0,635]
• Szurman P. Mysterium Glaskörper : Aufbau, Alterung und Ersatzstrategien. Ophthalmologe 2015; 112: 548 [IF 0,635]
• Kazerounian S, Szurman P, Waizel M. [Upper eyelid swelling]. Ophthalmologe 2015; 112: 691-693 [IF 0,635]
• Bonzheim I, Giese S, Deuter C, Süsskind D, Zierhut M, Waizel M, Szurman P, Federmann B, Schmidt J, Quintanilla-Martinez L, Coupland SE, Bartz-Schmidt KU. Fend F. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood 2015; 126: 76-79 [IF 10,452]
• Januschowski K, Müller S, Krupp C, Spitzer MS, Hurst J, Schultheiss M, Bartz-Schmidt KU, Szurman P, Schnichels S. Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina. J Vis Exp. 2015: 22 [IF 1.325]
• Alnahrawy O, Blumenstock G, Ziemssen F, Szurman P, Leitritz MA, Dimopoulos S, Voykov B. Exit strategies in canaloplasty: intraoperative conversion into 180-degree trabeculotomy or 360-degree trabeculotomy in cases of unsuccessful catheterisation of Schlemm's canal: influence of degree of canal cleavage. Graefes Arch Clin Exp Ophthalmol 2015; 253: 779-784 [IF 2.103]
• Voykov B, Szurman P, Dimopoulos S, Ziemssen F, Alnahrawy O. Micro-invasive suture trabeculotomy after canaloplasty: preliminary results. Clin Experiment Ophthalmol 2015; 43: 409-414 [IF 2.103]
• Januschowski K, Dimopoulos S, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G; Bevacizumab Study Group Venous Occlusion, Meyer CH, Szurman GB. Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. Acta Ophthalmol 2015: 93: 400-402 [IF 3.032]
• Kitiratschky VB, Deuter C, Beck R, Schulte B, Müller H, Blumenstock G, Szurman P. Relationship between suspected reasons of intraocular inflammation and the results of diagnostic vitrectomy: an observational study. Ocul Immunol Inflamm. 2015; 23: 59-66 [IF 1.972]